(HARTFORD, CT) Comptroller Natalie Braswell and Victoria Veltri, Executive Director of the Office of Health Strategy (OHS), announced today, the release of a new report that utilized the groundbreaking Connecticut Healthcare Affordability Index (CHAI) tool to analyze the effects of recent health care legislation.

(HARTFORD, CT) –The Connecticut Office of Health Strategy (OHS) announced today that it has approved, with conditions, the Certificate of Need application to allow Harford HealthCare Corporation and Yale New Haven Health Services Corporation to establish proton therapy services through a newly established joint venture, Connecticut Proton Therapy Center, LLC (“CPTC”). The 25,000 square-foot Proton Therapy Center will be located at 932 Northrop Road, Wallingford, CT. As part of this project, CPTC will utilize proton therapy, a type of radiation therapy that uses a high energy beam of protons to treat many solid cancer tumors, including tumors of the brain and central nervous system, eye, gastrointestinal tract, head and neck, liver, lung, prostate, spine, and some breast tumors.